Literature DB >> 15185866

Bell's palsy: a rare complication of interferon therapy for hepatitis C.

Inku Hwang, T Barry Calvit, Brooks D Cash, Kent C Holtzmuller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15185866     DOI： 10.1023/b:ddas.0000026389.56819.0c

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

1.  Cranial neuropathies and liver failure due to hepatitis A.

Authors:  L Varona; A Sagasta; J A Martin-Gonzálvez; J Ruiz; J J Zarranz
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

2.  Incidence and prognosis of Bell's palsy in the population of Rochester, Minnesota.

Authors:  W A Hauser; W E Karnes; J Annis; L T Kurland
Journal:  Mayo Clin Proc       Date:  1971-04       Impact factor: 7.616

Review 3.  Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years.

Authors:  F E Shaw; D J Graham; H A Guess; J B Milstien; J M Johnson; G C Schatz; S C Hadler; J N Kuritsky; E E Hiner; D J Bregman
Journal:  Am J Epidemiol       Date:  1988-02       Impact factor: 4.897

4.  Bell's palsy during interferon therapy for chronic hepatitis C infection in patients with haemorrhagic disorders.

Authors:  O Ogundipe; M Smith
Journal:  Haemophilia       Date:  2000-03       Impact factor: 4.287

5.  A survey of facial paralysis: etiology and incidence.

Authors:  J N Bleicher; S Hamiel; J S Gengler; J Antimarino
Journal:  Ear Nose Throat J       Date:  1996-06       Impact factor: 1.697

6.  Interferon anti-viral system in Bell's palsy.

Authors:  A Aviel; T Hahn; S Levin; E Ostfeld; V Bregman; G Marshak
Journal:  Acta Otolaryngol       Date:  1983 Jan-Feb       Impact factor: 1.494

Review 7.  Facial palsy and infection: the unfolding story.

Authors:  M Morgan; D Nathwani
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

8.  Seventh cranial nerve paralysis with myokymia during acute co-infection with hepatitis B and delta viruses.

Authors:  A Cargnel; C Davoli; P Vigano; M R Caccia; A R Zanetti; G Tovey; D S Ellis; A J Zuckerman
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327
  8 in total
  5 in total

1.  Bell's palsy and choreiform movements during peginterferon alpha and ribavirin therapy.

Authors:  Sener Barut; Hatice Karaer; Erol Oksuz; Asli Gündoğdu Eken; Ayse Nazli Basak
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

2.  Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.

Authors:  Eric Yuk Fai Wan; Celine Sze Ling Chui; Francisco Tsz Tsun Lai; Esther Wai Yin Chan; Xue Li; Vincent Ka Chun Yan; Le Gao; Qiuyan Yu; Ivan Chun Hang Lam; Raccoon Ka Cheong Chun; Benjamin John Cowling; Wing Chi Fong; Alexander Yuk Lun Lau; Vincent Chung Tong Mok; Frank Ling Fung Chan; Cheuk Kwong Lee; Lot Sze Tao Chan; Dawin Lo; Kui Kai Lau; Ivan Fan Ngai Hung; Gabriel Matthew Leung; Ian Chi Kei Wong
Journal:  Lancet Infect Dis       Date:  2021-08-16       Impact factor: 25.071

Review 3.  Type B insulin resistance developing during interferon-alpha therapy.

Authors:  Amanda L Daniel; Josetta L Houlihan; Janice S Blum; James P Walsh
Journal:  Endocr Pract       Date:  2009-03       Impact factor: 3.443

Review 4.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

Review 5.  Bell's Palsy and COVID-19 Vaccination: A Systematic Review.

Authors:  Kavous Shahsavarinia; Ata Mahmoodpoor; Fatemeh Sadeghi-Ghyassi; Arezou Nedayi; Alireza Razzaghi; Mahsa Zehi Saadat; Hanieh Salehi-Pourmehr
Journal:  Med J Islam Repub Iran       Date:  2022-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.